Search results for "Highlights"
In the Clinic, 2023 summary highlight gastroenterology topics
Colorectal cancer screening was the focus of the latest In the Clinic article, while an article in a supplement to Annals reviewed clinically important developments in gastroenterology and hepatology in 2023.
https://gastroenterology.acponline.org/archives/2024/04/26/5.htm
26 Apr 2024
Subscribe
ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
https://gastroenterology.acponline.org/subscribe/index.html
Risk for herpes zoster complications appears higher with IBD
A retrospective cohort study found that herpes zoster complications occurred in 15.52% of patients with inflammatory bowel disease (IBD) who got the virus versus 12.51% of those without IBD, a statistically significant difference.
https://gastroenterology.acponline.org/archives/2024/11/22/2.htm
22 Nov 2024
Only half of patients with SBP received albumin per guidelines, VA study finds
Use of albumin for spontaneous bacterial peritonitis (SBP) was lower among Black patients than White ones, but it did increase over time from 2008 to 2021, according to a retrospective Veterans Affairs (VA) study.
https://gastroenterology.acponline.org/archives/2024/11/22/3.htm
22 Nov 2024
Spotlight on newer methods of CRC screening
Recent analyses compared a multitarget stool DNA test for colorectal cancer (CRC) with fecal immunochemical testing (FIT), assessed the cost-effectiveness of new cell-free blood DNA tests for CRC, and looked at a FIT-based screening strategy for lower-income countries.
https://gastroenterology.acponline.org/archives/2024/11/22/5.htm
22 Nov 2024
Adding factors to FIB-4 improves early identification of patients with risk of HCC
The score, which took into account age, sex, race and ethnicity, body mass index, diabetes status, smoking status, alcohol use, and Fibrosis-4 Index (FIB-4) score, found patients at risk of hepatocellular cancer (HCC) who didn't have viral hepatitis or cirrhosis.
https://gastroenterology.acponline.org/archives/2024/11/22/1.htm
22 Nov 2024
Spotlight on liver health in diabetes
A review compared liver outcomes for most classes of diabetes drugs, while a retrospective study looked at glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors head to head. Another study offered a new score for metabolic dysfunction-associated steatotic liver disease.
https://gastroenterology.acponline.org/archives/2024/10/25/8.htm
25 Oct 2024
AI-assisted colonoscopy does not improve detection of advanced neoplasias
While colonoscopies with artificial intelligence (AI) assistance yielded more adenomas compared with conventional colonoscopy, rates of advanced neoplasias per colonoscopy did not differ, a systematic review and meta-analysis found.
https://gastroenterology.acponline.org/archives/2024/10/25/2.htm
25 Oct 2024
Elimination diets, PPIs most cost-effective for EoE treatment
Elimination diets were the most cost-effective strategy for treatment of eosinophilic esophagitis (EoE) over a five-year period, while proton-pump inhibitors (PPIs) were the most cost-effective first-line drugs, a recent study found.
https://gastroenterology.acponline.org/archives/2024/10/25/3.htm
25 Oct 2024
Fecal immunochemical tests vary widely in sensitivity, specificity
The test positivity rate among five commonly used fecal immunochemical tests varied from 3.9% to 16.4%, and rates of unevaluable tests ranged from 0.2% to 2.5%. The sensitivity for advanced neoplasia varied from 10.1% to 36.7%, and specificity varied from 85.5% to 96.6%.
https://gastroenterology.acponline.org/archives/2024/09/27/2.htm
27 Sep 2024